Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Tissue Transplantation01:24

Tissue Transplantation

271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.

European journal of haematology·2026
Same author

Epigenetic insights into minimal residual disease detection in cancer.

Genes & diseases·2026
Same author

Analysis of Linezolid Blood Concentration and Prediction Modeling of Thrombocytopenia in Orthopedic Patients.

Surgical infections·2025
Same author

Optimizing RNA quality in cryopreserved tissues without preservatives: impact of preservatives, thawing methods and tissue aliquot sizes.

BMC biotechnology·2025
Same author

Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case Series.

ImmunoTargets and therapy·2025
Same author

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

Cancer communications (London, England)·2025

Related Experiment Video

Updated: May 7, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

844

Hematopoietic stem cell microtransplantation: current situation and challenges.

Zhengyang Li1, Yuanyuan Yang1, Hongwei Peng2

  • 1Center of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Therapeutic Advances in Hematology
|January 6, 2025
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cell microtransplantation (MST) offers a novel approach to hematological malignancies by combining treatments to improve survival and reduce graft-versus-host disease (GVHD). This strategy enhances graft-versus-tumor response while preserving immune function.

Keywords:
GVHDMSThematological malignancieshematopoietic stem cellimmunotherapymicrotransplantation

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

364
Isolation and Transplantation of Hematopoietic Stem Cells HSCs
20:38

Isolation and Transplantation of Hematopoietic Stem Cells HSCs

Published on: February 25, 2007

23.6K

Related Experiment Videos

Last Updated: May 7, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

844
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

364
Isolation and Transplantation of Hematopoietic Stem Cells HSCs
20:38

Isolation and Transplantation of Hematopoietic Stem Cells HSCs

Published on: February 25, 2007

23.6K

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is effective for hematological malignancies but limited by graft-versus-host disease (GVHD), a major cause of mortality.
  • GVHD remains a significant barrier to allo-HSCT, impacting patient outcomes and quality of life.

Purpose of the Study:

  • To review the mechanisms, clinical applications, and challenges of hematopoietic stem cell microtransplantation (MST).
  • To explore MST's potential to improve treatment for hematological malignancies by minimizing GVHD and enhancing graft-versus-tumor (GVT) responses.

Main Methods:

  • Review of existing literature on MST in hematological malignancies.
  • Analysis of MST's synergistic combination of chemotherapy, allo-HSCT, and cellular immunotherapy.

Main Results:

  • MST demonstrates promising outcomes in hematological malignancies, including improved complete remission, overall survival, and progression-free survival rates.
  • MST facilitates hematopoietic recovery, reduces infection risk, and significantly lowers the incidence of GVHD.
  • The approach aims to retain patient immune function and promote microchimerism for a potent GVT response.

Conclusions:

  • MST is a novel therapeutic strategy with the potential to overcome the limitations of traditional allo-HSCT.
  • Further understanding of MST mechanisms can enhance its clinical utility and integration into standard cancer treatment protocols.